was read the article
array:23 [ "pii" => "S2173572712000781" "issn" => "21735727" "doi" => "10.1016/j.medine.2012.01.007" "estado" => "S300" "fechaPublicacion" => "2012-05-01" "aid" => "432" "copyright" => "Elsevier España, S.L. and SEMICYUC" "copyrightAnyo" => "2011" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Med Intensiva. 2012;36:277-87" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3606 "formatos" => array:3 [ "EPUB" => 144 "HTML" => 2526 "PDF" => 936 ] ] "itemSiguiente" => array:18 [ "pii" => "S2173572712000835" "issn" => "21735727" "doi" => "10.1016/j.medine.2012.06.005" "estado" => "S300" "fechaPublicacion" => "2012-05-01" "aid" => "391" "copyright" => "Elsevier España, S.L. and SEMICYUC" "documento" => "article" "crossmark" => 0 "subdocumento" => "sco" "cita" => "Med Intensiva. 2012;36:288-93" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2867 "formatos" => array:3 [ "EPUB" => 135 "HTML" => 1936 "PDF" => 796 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Point of view</span>" "titulo" => "Daily interruption of sedation: Always a quality indicator?" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "288" "paginaFinal" => "293" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Interrupción diaria de la sedación; ¿ siempre es un indicador de calidad?" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 718 "Ancho" => 2160 "Tamanyo" => 76244 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Time–plasma concentration curve of a sedating agent administered as a perfusion. After 4–5 half-lives (<span class="elsevierStyleItalic">t</span><span class="elsevierStyleInf">1/2</span>), the concentration reaches the steady-state condition (point A), where equal amounts of drug substance are administered and eliminated simultaneously–the plasma concentration thus remaining constant. At point B the decision is made to reduce the amount of drug in the patient with the purpose of reaching the effect corresponding to plasma concentration “x” (Cx). The thin tracing shows the drop in plasma concentration on readjusting the infusion, while the thick tracing corresponds to suspension of the perfusion.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "T. Muñoz-Martínez" "autores" => array:1 [ 0 => array:2 [ "nombre" => "T." "apellidos" => "Muñoz-Martínez" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173572712000835?idApp=WMIE" "url" => "/21735727/0000003600000004/v1_201212101018/S2173572712000835/v1_201212101018/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S2173572712000859" "issn" => "21735727" "doi" => "10.1016/j.medine.2012.06.006" "estado" => "S300" "fechaPublicacion" => "2012-05-01" "aid" => "374" "copyright" => "Elsevier España, S.L. and SEMICYUC" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Med Intensiva. 2012;36:270-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2518 "formatos" => array:3 [ "EPUB" => 127 "HTML" => 1757 "PDF" => 634 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original</span>" "titulo" => "Foreseeable variation in parameters measured at implant and follow-up of permanent pacemaker active fixation electrodes" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "270" "paginaFinal" => "276" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Variación esperable de parámetros medidos en el implante y seguimiento de electrodos de fijación activa de marcapasos definitivos" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1283 "Ancho" => 2337 "Tamanyo" => 119849 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Evolution of impedances in the first 6 months. Square boxes: values of the ventricular electrodes. Rhomboid boxes: values of the atrial electrodes, measured in Ω.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "A. Canabal, V. Hortigüela, A. Raigal, P. Sánchez, M. Sánchez, C. Marco, E. Fernández, J.A. Márquez" "autores" => array:8 [ 0 => array:2 [ "nombre" => "A." "apellidos" => "Canabal" ] 1 => array:2 [ "nombre" => "V." "apellidos" => "Hortigüela" ] 2 => array:2 [ "nombre" => "A." "apellidos" => "Raigal" ] 3 => array:2 [ "nombre" => "P." "apellidos" => "Sánchez" ] 4 => array:2 [ "nombre" => "M." "apellidos" => "Sánchez" ] 5 => array:2 [ "nombre" => "C." "apellidos" => "Marco" ] 6 => array:2 [ "nombre" => "E." "apellidos" => "Fernández" ] 7 => array:2 [ "nombre" => "J.A." "apellidos" => "Márquez" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173572712000859?idApp=WMIE" "url" => "/21735727/0000003600000004/v1_201212101018/S2173572712000859/v1_201212101018/en/main.assets" ] "en" => array:19 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Consensus statement</span>" "titulo" => "Summary of the consensus document: “Clinical practice guide for the management of low cardiac output syndrome in the postoperative period of heart surgery”" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "277" "paginaFinal" => "287" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "J.L. Pérez Vela, J.C. Martín Benitez, M. Carrasco Gonzalez, M.A. de la Cal López, R. Hinojosa Pérez, V. Sagredo Meneses, F. del Nogal Saez" "autores" => array:8 [ 0 => array:4 [ "nombre" => "J.L." "apellidos" => "Pérez Vela" "email" => array:1 [ 0 => "perezvela@yahoo.es" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">¿</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "J.C." "apellidos" => "Martín Benitez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "M." "apellidos" => "Carrasco Gonzalez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 3 => array:3 [ "nombre" => "M.A." "apellidos" => "de la Cal López" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 4 => array:3 [ "nombre" => "R." "apellidos" => "Hinojosa Pérez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">e</span>" "identificador" => "aff0025" ] ] ] 5 => array:3 [ "nombre" => "V." "apellidos" => "Sagredo Meneses" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "aff0030" ] ] ] 6 => array:3 [ "nombre" => "F." "apellidos" => "del Nogal Saez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">g</span>" "identificador" => "aff0035" ] ] ] 7 => array:1 [ "colaborador" => "Grupo de Trabajo de Cuidados Intensivos Cardiológicos y RCP de SEMICYUC, «con el aval científico de la SEMICYUC»" ] ] "afiliaciones" => array:7 [ 0 => array:3 [ "entidad" => "Servicio de Medicina intensiva, Hospital Universitario 12 de Octubre, Madrid, Spain" "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Medicina intensiva, Hospital Clínico Universitario San Carlos, Madrid, Spain" "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Unidad Postoperatoria de Cirugía Cardiaca, Hospital Vall d’Hebron, Barcelona, Spain" "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Servicio de Medicina intensiva, Hospital Universitario de Getafe, Madrid, Spain" "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] 4 => array:3 [ "entidad" => "Servicio de Medicina intensiva, Hospital Universitario Virgen del Rocío, Sevilla, Spain" "etiqueta" => "<span class="elsevierStyleSup">e</span>" "identificador" => "aff0025" ] 5 => array:3 [ "entidad" => "Servicio de Medicina intensiva, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain" "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "aff0030" ] 6 => array:3 [ "entidad" => "Servicio de Medicina intensiva, Hospital Universitario Severo Ochoa, Leganés, Madrid, Spain" "etiqueta" => "<span class="elsevierStyleSup">g</span>" "identificador" => "aff0035" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Resumen del documento de consenso «Guías de práctica clínica para el manejo del síndrome de bajo gasto cardiaco en el postoperatorio de cirugía cardiaca»" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Concept</span><p id="par0150" class="elsevierStylePara elsevierViewall">Low cardiac output syndrome (LCOS) in the postoperative period of heart surgery (PHS) is a potential complication in heart surgery (HS) patients. Its reported incidence varies between 3 and 45%, depending on the literature source, and the syndrome is associated to an increase in morbidity–mortality, a prolongation of stay in the Intensive Care Unit (ICU), and an increase in resource utilization.<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1–3</span></a> LCOS is a broad concept, and the literature also offers other terms or designations such as postoperative myocardial dysfunction, postoperative cardiocirculatory dysfunction, acute cardiovascular dysfunction, postsurgery heart failure, heart failure or postcardiotomy shock. The origin and form of presentation of LCOS differ from those of medical acute heart failure (AHF). Consequently, the AHF classifications of the European Society of Cardiology (ESC) and of the American College of Cardiology (ACC) are not directly applicable to the postoperative PHS.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a></p><p id="par0155" class="elsevierStylePara elsevierViewall">Morbidity–mortality in the postoperative phase of HS has evolved favorably in recent years. This is probably a result of improvements at all implicated healthcare levels, including surgery (surgical technique, myocardial protection, etc.), anesthesia, monitorization, and postoperative management and treatment. The sum of these improvements has encouraged surgeons to operate upon increasingly older patients and with greater comorbidity, i.e., individuals more likely to develop complications, including hemodynamic problems.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Objectives of the guide</span><p id="par0160" class="elsevierStylePara elsevierViewall">The present guide aims to offer recommendations for the management of adult patients with LCOS in the immediate postoperative period of HS, admitted to the ICU. The recommendations are based on consensus among experts in Intensive Care Medicine with special dedication to PHS, as well as an intensivist with expertise in methodological issues. The guide is transparent in reference to the literature supporting the recommendations and the level of evidence, as well as regards the methodology used to develop the guide. This makes it reproducible and applicable in the different ICUs.</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Scope of the guide</span><p id="par0165" class="elsevierStylePara elsevierViewall">The recommendations have been grouped into different sections, attempting to address aspects ranging from the more basic concepts such as definitions (where homogeneity is lacking in the literature) to the different basic and advanced monitorization areas in these patients, and the complex management of LCOS. Management in turn ranges from drug treatments available in any center to the most complex procedures such as mechanical circulatory assist techniques and heart transplantation. Lastly, the guide offers a series of simple algorithms applicable to the initial patient management and to the treatment of predominantly left or right ventricle failure.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Limitations of the guide</span><p id="par0170" class="elsevierStylePara elsevierViewall">Most of the recommendations are based on expert consensus, due to the lack of randomized clinical studies of adequate design and sample size in patients of this kind. On the other hand, the guide does not address the pediatric population.</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Users</span><p id="par0175" class="elsevierStylePara elsevierViewall">This guide has been developed for consultation and use by physicians involved in the perioperative management of HS or, in reference to the more general aspects, by physicians implicated in cardiac critical care. It can also prove useful for teaching activities targeted to intensivists or residents in training.</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Methodology for development of the guide</span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Conformation of the group</span><p id="par0180" class="elsevierStylePara elsevierViewall">Under the auspices of the Cardiological Intensive Care Working Group of the Sociedad Española de Medicina Intensiva, Critica y Unidades Coronarias (SEMICYUC), a group of experts gathered with especial dedication to PHS and working in different Autonomous Communities all over Spain. In addition, an intensivist with expertise in methodological issues also participated in the project from the start—providing orientation and support in the literature searches, and contributing to the methodology and development of the guide.</p><p id="par0185" class="elsevierStylePara elsevierViewall">The members of the Working Group established the issues of particular interest to be addressed in the context of LCOS. In this sense, systematic literature searches were made, and after due analysis of the data, a series of initial recommendations were discussed and established among the different members of the group. The text and initial recommendations in turn were submitted to a group of intensivists with special experience and dedication to patients in the context of PHS (Appendix 1 can be consulted in the full version, doi:10.1016/j.medin.2012.02.007. Based on the contributions of these intensivists and on common consensus, established on occasion of the meeting of the Cardiological Intensive Care Working Group of the SEMICYUC at the National Congress of the SEMICYUC 2011, the final conclusions to the document were drawn.</p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Biomedical literature search and development of the guide</span><p id="par0190" class="elsevierStylePara elsevierViewall">Development of the guidelines was based on a MEDLINE search of publications up until December 2010. Since the biomedical literature can cite LCOS in different terms, randomized clinical trials were sought, together with reviews, cohort studies, case–control studies, descriptive observational studies and case series using the following keywords: <span class="elsevierStyleItalic">post/perioperative low cardiac output syndrome, postcardiotomy heart/cardiac failure, postcardiotomy cardiogenic shock (CS), post/perioperative cardiac/heart failure, transient ventricular dysfunction or myocardial stunning, and low post-cardiac surgery cardiac output (CO)</span>. These terms in turn were crossed in each of the sections addressed in this guide: monitorization, inotropic drugs, etc. As a starting point, use was made of the only guides available to date on the hemodynamic management and treatment of HS patients, based on the literature review and experts opinion survey recently published by the Association of the Scientific Medical Societies in Germany.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> In addition, secondary literature references were used (identified from the analyzed studies found in the literature search), together with general recommendations and guidelines referred to heart failure, arrhythmias and monitorization.</p><p id="par0195" class="elsevierStylePara elsevierViewall">The quality of the evidence and the strength of the recommendations were defined following the methodology of the GRADE (Grading of Recommendation Assessment, Development and Evaluation) Working Group.<a class="elsevierStyleCrossRefs" href="#bib0030"><span class="elsevierStyleSup">6,7</span></a> This system is based on the sequential assessment of the quality of the evidence (taking into account the design and quality of the study, consistency, and the direct-indirect evidence) and the possible recommendations. Thus, the quality of the evidence is classified as high (grade A), moderate (grade B), low (grade C) or very low (grade D) (Table 1 can be consulted in the full version, doi:10.1016/j.medin.2012.02.007), and the recommendations are defined as strong (grade 1) or weak (grade 2). Grading of the recommendations as either strong or weak is conditioned more by clinical importance than by the quality of the evidence. A strong recommendation in favor of a given intervention indicates that the desirable effects obtained on applying the recommendation clearly outweigh the undesirable effects, and means “we recommend”. In contrast, a weak recommendation in favor of an intervention indicates that the undesirable effects will probably outweigh the desirable effects, and means “we suggest” (Table 1 can be consulted in the full version, doi:10.1016/j.medin.2012.02.007).</p><p id="par0200" class="elsevierStylePara elsevierViewall">The guide is presented as a list of recommendations (with the level of evidence of each recommendation) for each issue or question in the selected topic. Then, in each concrete question, justification of the recommendations is provided. Given the large dimensions of the full guide, the present text offers an abridged version addressing only the recommendations. The full text, which includes the justifications of the recommendations and the total 483 literature references, can be accessed at: doi:10.1016/j.medin.2012.02.007.</p></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Updating of the guide</span><p id="par0205" class="elsevierStylePara elsevierViewall">Updating of the guide every four years from the date of publication is proposed, in order to adapt the recommendations to the results and findings of the new clinical studies.</p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Exoneration</span><p id="par0210" class="elsevierStylePara elsevierViewall">The guide is a useful tool for improving medical decisions, but in any case, the recommendations of such documents are not meant to replace the decision making capacity of the clinician in a concrete situation or circumstance and involving specific clinical variables. Application of the recommendations also depends on the availability of means and resources in each center or institution. On the other hand, new clinical research findings may produce new evidence requiring a change in routine clinical practice even before this guide is updated.</p></span></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">How could we define low cardiac output syndrome in the postoperative period of heart surgery?</span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Recommendation</span><p id="par0215" class="elsevierStylePara elsevierViewall">The following definitions are recommended:<ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><span class="elsevierStyleLabel">1.</span><p id="par0220" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Postoperative LCOS:</span> Measured cardiac index (CI)<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>2.2<span class="elsevierStyleHsp" style=""></span>l/min/m<span class="elsevierStyleSup">2</span>, without associated relative hypovolemia. It may be due to left and/or right ventricle failure and can be accompanied or not by pulmonary congestion. Blood pressure may be normal or low.</p></li><li class="elsevierStyleListItem" id="lsti0010"><span class="elsevierStyleLabel">2.</span><p id="par0225" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Clinical condition consistent with LCOS:</span> This would apply to patients in which CO is not monitored, and is not known, but in whom the clinical manifestations are consistent with low CO, i.e., oliguria (diuresis<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.5<span class="elsevierStyleHsp" style=""></span>ml/kg/h), central venous saturation<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>60% (with normal arterial saturation) and/or lactate<span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>3<span class="elsevierStyleHsp" style=""></span>mmol/l, without relative hypovolemia. This group should also include those patients coming from the operating room with inotropic medication and/or an intraaortic counterpulsation balloon pump (IABP), and in which these measures must be maintained to secure adequate hemodynamic conditions.</p></li><li class="elsevierStyleListItem" id="lsti0015"><span class="elsevierStyleLabel">3.</span><p id="par0230" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">CS:</span> This is the most serious situation in the context of LCOS, and is defined as CI<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>2.0<span class="elsevierStyleHsp" style=""></span>l/min/m<span class="elsevierStyleSup">2</span>, with SBP<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>90<span class="elsevierStyleHsp" style=""></span>mmHg, without relative hypovolemia, and with oliguria.</p></li></ul></p></span></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Is low cardiac output syndrome acute heart failure?</span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Recommendation</span><p id="par0235" class="elsevierStylePara elsevierViewall">LCOS could be regarded as AHF with differences referred to its etiology, physiopathology and course versus the forms of clinical AHF contemplated in the classifications proposed by the ESC and ACC/AHA.</p></span></span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Can we identify risk factors for the development of low cardiac output syndrome?</span><span id="sec0080" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Recommendation</span><p id="par0240" class="elsevierStylePara elsevierViewall">No known individual risk factor is able to predict the development of LCOS in the PHS (2D).</p></span></span><span id="sec0085" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">What are the basic monitorization needs in the postoperative period of heart surgery?</span><span id="sec0090" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Recommendations</span><p id="par0245" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0010"><li class="elsevierStyleListItem" id="lsti0020"><span class="elsevierStyleLabel">1.</span><p id="par0250" class="elsevierStylePara elsevierViewall">Monitorization in the PHS should be adapted to the clinical situation of the patient (1C).</p></li><li class="elsevierStyleListItem" id="lsti0025"><span class="elsevierStyleLabel">2.</span><p id="par0255" class="elsevierStylePara elsevierViewall">The recommended basic monitorization measures for clinically stable patients comprise continuous electrocardiographic monitoring, systemic arterial oxygen saturation, invasive arterial pressure recording, fluid balance (diuresis, drains), and the measurement of central venous pressure (CVP) (1D).</p></li><li class="elsevierStyleListItem" id="lsti0030"><span class="elsevierStyleLabel">3.</span><p id="par0260" class="elsevierStylePara elsevierViewall">In low risk patients, monitorization with CVP is considered sufficient, with no need for pulmonary artery catheterization (PAC) or other systems for the measurement of CO or venous oxygen saturation (SvO<span class="elsevierStyleInf">2</span>) on a continuous basis (1B).</p></li><li class="elsevierStyleListItem" id="lsti0035"><span class="elsevierStyleLabel">4.</span><p id="par0265" class="elsevierStylePara elsevierViewall">The use of other devices or techniques will depend on the surgical complexity, the clinical situation and the postoperative course with patient instability (1D).</p></li></ul></p></span></span><span id="sec0095" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">In which patients should advanced hemodynamic monitorization be considered?</span><span id="sec0100" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Recommendation</span><p id="par0270" class="elsevierStylePara elsevierViewall">Advanced hemodynamic monitorization is advised in postoperative patients showing hemodynamic instability or suspected LCOS, and who fail to respond to the initial management measures (1C) (Fig. 1 can be consulted in the full version, doi:10.1016/j.medin.2012.02.007).</p></span></span><span id="sec0105" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">How can we estimate preload?</span><span id="sec0110" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Recommendations</span><p id="par0275" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0015"><li class="elsevierStyleListItem" id="lsti0040"><span class="elsevierStyleLabel">1.</span><p id="par0280" class="elsevierStylePara elsevierViewall">The evaluation of preload must be made with integration of the clinical data, the information obtained from the different monitorization techniques, and the dynamic response to the adopted treatment measures. A dynamic response on the part of preload as determined after volume expansion is considered fundamental (1D).</p></li><li class="elsevierStyleListItem" id="lsti0045"><span class="elsevierStyleLabel">2.</span><p id="par0285" class="elsevierStylePara elsevierViewall">It is not advisable to adopt preload modifying measures on the basis of isolated data obtained by a given technique or procedure (1D).</p></li><li class="elsevierStyleListItem" id="lsti0050"><span class="elsevierStyleLabel">3.</span><p id="par0290" class="elsevierStylePara elsevierViewall">The extreme values of CVP offer us information on the situation of preload, though as occurs with the data obtained by other methods, this information must be integrated with the clinical situation of the patient and the data drawn from other explorations (1D).</p></li><li class="elsevierStyleListItem" id="lsti0055"><span class="elsevierStyleLabel">4.</span><p id="par0295" class="elsevierStylePara elsevierViewall">In situations of suspected LCOS, it is advisable to assess the information provided by other methods, which moreover afford additional hemodynamic information—particularly echocardiography (EG) and CO measurement systems (1D).</p></li></ul></p></span></span><span id="sec0115" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">In which patients should we know cardiac output in the postoperative period of heart surgery?</span><span id="sec0120" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Recommendations</span><p id="par0300" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0020"><li class="elsevierStyleListItem" id="lsti0060"><span class="elsevierStyleLabel">1.</span><p id="par0305" class="elsevierStylePara elsevierViewall">Routine CO monitoring is not advised in patients with an uncomplicated PHS (1C).</p></li><li class="elsevierStyleListItem" id="lsti0065"><span class="elsevierStyleLabel">2.</span><p id="par0310" class="elsevierStylePara elsevierViewall">Ventricle function should be assessed in the PHS in situations of clinical instability and/or suspected LCOS (1C).</p></li><li class="elsevierStyleListItem" id="lsti0070"><span class="elsevierStyleLabel">3.</span><p id="par0315" class="elsevierStylePara elsevierViewall">There are no recommendations for the choice of a specific method. The decision should depend on the conditions of the patient, availability, and the experience of the attending medical team (1D).</p></li><li class="elsevierStyleListItem" id="lsti0075"><span class="elsevierStyleLabel">4.</span><p id="par0320" class="elsevierStylePara elsevierViewall">In patients with prior moderate to severe pulmonary hypertension (PHT), the recommendation is to use PAC (1D).</p></li></ul></p></span></span><span id="sec0125" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">What role does the echocardiogram play in the postoperative period of heart surgery?</span><span id="sec0130" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Recommendations</span><p id="par0325" class="elsevierStylePara elsevierViewall">EG offers relevant information in postoperative patients with clinical stability, and in cases of suspected LCOS. Therefore:<ul class="elsevierStyleList" id="lis0025"><li class="elsevierStyleListItem" id="lsti0080"><span class="elsevierStyleLabel">1.</span><p id="par0330" class="elsevierStylePara elsevierViewall">EG is recommended in the PHS in patients with persistent hypotension or hypoxemia who fail to respond to the initial therapeutic measures, and in which no apparent cause is identified (1C) (Fig. 1 can be consulted in the full version, doi:10.1016/j.medine.xxxx.xx.xxx).</p></li><li class="elsevierStyleListItem" id="lsti0085"><span class="elsevierStyleLabel">2.</span><p id="par0335" class="elsevierStylePara elsevierViewall">Echocardiography is recommended in patients with suspected LCOS (1C).</p></li><li class="elsevierStyleListItem" id="lsti0090"><span class="elsevierStyleLabel">3.</span><p id="par0340" class="elsevierStylePara elsevierViewall">TEE is advised when the information cannot be obtained by TTE or other means (1C).</p></li><li class="elsevierStyleListItem" id="lsti0095"><span class="elsevierStyleLabel">4.</span><p id="par0345" class="elsevierStylePara elsevierViewall">It is advisable to have TEE available in the PHS in all centers where heart surgery is carried out (2D).</p></li><li class="elsevierStyleListItem" id="lsti0100"><span class="elsevierStyleLabel">5.</span><p id="par0350" class="elsevierStylePara elsevierViewall">Continuous transesophageal Doppler is not advised for monitorization in the PHS (2C).</p></li></ul></p></span></span><span id="sec0135" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Should venous oxygen saturation be determined?</span><span id="sec0140" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Recommendation</span><p id="par0355" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0030"><li class="elsevierStyleListItem" id="lsti0105"><span class="elsevierStyleLabel">1.</span><p id="par0360" class="elsevierStylePara elsevierViewall">Its routine use cannot be recommended, though the measurement of venous oxygen saturation (SvO<span class="elsevierStyleInf">2</span> or central venous oxygen saturation [ScvO<span class="elsevierStyleInf">2</span>]) is useful for the identification and management of patients with suspected or established LCOS (2C).</p></li><li class="elsevierStyleListItem" id="lsti0110"><span class="elsevierStyleLabel">2.</span><p id="par0365" class="elsevierStylePara elsevierViewall">The serial determination of SvO<span class="elsevierStyleInf">2</span> or ScvO<span class="elsevierStyleInf">2</span> may be useful for assessing the efficacy of the adopted measures, though it has limitations (2D).</p></li></ul></p></span></span><span id="sec0145" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Should we determine lactate in the postoperative period of heart surgery?</span><span id="sec0150" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Recommendations</span><p id="par0370" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0035"><li class="elsevierStyleListItem" id="lsti0115"><span class="elsevierStyleLabel">1.</span><p id="par0375" class="elsevierStylePara elsevierViewall">Initial lactate measurement in the PHS is advised (2C).</p></li><li class="elsevierStyleListItem" id="lsti0120"><span class="elsevierStyleLabel">2.</span><p id="par0380" class="elsevierStylePara elsevierViewall">In the same way as in other critical patients, lactate clearance in the PHS informs us of a favorable/unfavorable trend in the clinical course, and as such may be useful for assessing the patient condition (2C).</p></li></ul></p></span></span><span id="sec0155" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">What are the general hemodynamic objectives in the management of a patient with low cardiac output syndrome?</span><span id="sec0160" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Recommendation</span><p id="par0385" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0040"><li class="elsevierStyleListItem" id="lsti0125"><span class="elsevierStyleLabel">1.</span><p id="par0390" class="elsevierStylePara elsevierViewall">Table 3 describes the general hemodynamic objectives in LCOS (1D) (Table 3 can be consulted in the full version, doi:10.1016/j.medin.2012.02.007).</p></li><li class="elsevierStyleListItem" id="lsti0130"><span class="elsevierStyleLabel">2.</span><p id="par0395" class="elsevierStylePara elsevierViewall">Fig. 1 shows the recommended algorithm for the initial management of LCOS (1D) (Fig. 1 can be consulted in the full version, doi:10.1016/j.medin.2012.02.007).</p></li></ul></p></span></span><span id="sec0165" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Is it important to control heart rate and cardiac rhythm? How should arrhythmias be dealt with?</span><span id="sec0170" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Recommendation</span><p id="par0400" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0045"><li class="elsevierStyleListItem" id="lsti0135"><span class="elsevierStyleLabel">1.</span><p id="par0405" class="elsevierStylePara elsevierViewall">In bradyarrhythmias with hemodynamic repercussions, epicardial pacing is to be maintained in order to secure adequate hemodynamic conditions (1D).</p></li><li class="elsevierStyleListItem" id="lsti0140"><span class="elsevierStyleLabel">2.</span><p id="par0410" class="elsevierStylePara elsevierViewall">Tachyarrhythmias with hemodynamic repercussions require urgent treatment (1B).</p></li><li class="elsevierStyleListItem" id="lsti0145"><span class="elsevierStyleLabel">3.</span><p id="par0415" class="elsevierStylePara elsevierViewall">Synchronized electric cardioversion is advised in atrial fibrillation/flutter, in order to restore sinus node rhythm in patients with severe hemodynamic alterations or myocardial ischemia (1B).</p></li><li class="elsevierStyleListItem" id="lsti0150"><span class="elsevierStyleLabel">4.</span><p id="par0420" class="elsevierStylePara elsevierViewall">In patients with atrial fibrillation/flutter and less serious hemodynamic alterations, the recommendation is to administer intravenous amiodarone (1B). When the arrhythmia is not accompanied by hemodynamic instability, ventricle frequency should be controlled (1B).</p></li></ul></p><p id="par0425" class="elsevierStylePara elsevierViewall">Fig. 2 shows a simplified form of the arrhythmia management algorithm (Fig. 2 can be consulted in the full version, doi:10.1016/j.medin.2012.02.007).</p></span></span><span id="sec0175" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">From what hemoglobin levels do these patients require transfusion?</span><span id="sec0180" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Recommendation</span><p id="par0430" class="elsevierStylePara elsevierViewall">There is no defined hemoglobin concentration threshold below which transfusion is indicated in patients without hemorrhagic shock or without acute bleeding, in the presence of hemodynamic instability. Transfusion is reasonable in most patients in the PHS when hemoglobin <7<span class="elsevierStyleHsp" style=""></span>g/dl (1D).</p></span></span><span id="sec0185" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">What inotropic drugs and vasopressors may be useful in the management of low cardiac output syndrome? Is there any “best” option?</span><span id="sec0190" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Recommendations</span><p id="par0435" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0050"><li class="elsevierStyleListItem" id="lsti0155"><span class="elsevierStyleLabel">1.</span><p id="par0440" class="elsevierStylePara elsevierViewall">It is not advisable to administer inotropic drugs based only on the measurement of CO as an isolated parameter. Such medication is recommended in the presence of some accompanying clinical manifestation of LCOS (1D).</p></li><li class="elsevierStyleListItem" id="lsti0160"><span class="elsevierStyleLabel">2.</span><p id="par0445" class="elsevierStylePara elsevierViewall">It is not advisable to attempt to normalize or optimize a single hemodynamic parameter with inotropic drugs or vasopressors without taking the global clinical context into account. The previously mentioned hemodynamic objectives must be kept in mind (1D) (Table 3 can be consulted in the full version, doi:10.1016/j.medin.2012.02.007).</p></li><li class="elsevierStyleListItem" id="lsti0165"><span class="elsevierStyleLabel">3.</span><p id="par0450" class="elsevierStylePara elsevierViewall">Inotropic drugs and vasopressors are recommended in the circumstances contemplated in the algorithms (1C) (Figs. 3 and 4 can be consulted in the full version, doi:10.1016/j.medin.2012.02.007).</p></li><li class="elsevierStyleListItem" id="lsti0170"><span class="elsevierStyleLabel">4.</span><p id="par0455" class="elsevierStylePara elsevierViewall">Inotropic drugs and vasopressors are recommended to increase CO and vascular tone, both of which are altered in LCOS during the PHS, until the patient has clinically recovered from the syndrome (2D).</p></li><li class="elsevierStyleListItem" id="lsti0175"><span class="elsevierStyleLabel">5.</span><p id="par0460" class="elsevierStylePara elsevierViewall">No specific inotropic drug or vasopressor can be recommended. It is advisable to use the management algorithms in Figs. 3 and 4 as a general reference, and also to consider the clinical experience and drug availabilities in each particular center (1D) (Figs. 3 and 4 can be consulted in the full version, doi:10.1016/j.medin.2012.02.007).</p></li></ul></p><p id="par0465" class="elsevierStylePara elsevierViewall">The clinical indications for the intravenous administration of inotropic drugs in heart surgery patients comprise supportive treatment in weaning from extracorporeal circulation (ECC), LCOS in the PHS, and CS. However, it has not been clearly defined when the patient requires medication or of what kind (purely vasopressors or inotropic agents), or which drug is best - since there are no adequately designed randomized clinical trials offering sufficiently solid evidence, despite the large number of patients subjected to heart surgery. Appendixes 2 and 3 (can be consulted in the full version, doi:10.1016/j.medin.2012.02.007) summarize the most important clinical studies with inotropic drugs in adult patients subjected to heart surgery, and in patients with low CO–CS.<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">8–80</span></a></p><p id="par0470" class="elsevierStylePara elsevierViewall">At general level, the ESC guides 2005<a class="elsevierStyleCrossRef" href="#bib0405"><span class="elsevierStyleSup">81</span></a> and 2008<a class="elsevierStyleCrossRef" href="#bib0410"><span class="elsevierStyleSup">82</span></a> on the diagnosis and treatment of AHF advise (strong recommendation, with low level of evidence) the use of inotropic agents in the presence of peripheral hypoperfusion, with or without congestion or lung edema, refractory to diuretics and vasodilators at optimum doses. In turn, the AHA/ACC<a class="elsevierStyleCrossRef" href="#bib0415"><span class="elsevierStyleSup">83</span></a> guides (with weak recommendation and low level of evidence) consider that dopamine, dobutamine and milrinone can reduce the congestive symptoms and should be reserved for carefully selected patients with low blood pressure, severe systolic dysfunction and evidence of lowered CO, with a view to maintaining systemic perfusion.</p></span></span><span id="sec0195" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Algorithm for the management of predominant left ventricle failure</span><span id="sec0200" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Recommendation</span><p id="par0475" class="elsevierStylePara elsevierViewall">Fig. 3 shows the algorithm for the recommended management of predominant left ventricle failure in LCOS during the PHS (1D) (Fig. 3 can be consulted in the full version, doi:10.1016/j.medin.2012.02.007).</p></span></span><span id="sec0205" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Algorithm for the management of predominant right ventricle failure</span><span id="sec0210" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Recommendation</span><p id="par0480" class="elsevierStylePara elsevierViewall">Fig. 4 shows the algorithm for the recommended management of predominant right ventricle failure in LCOS during the PHS (1D) (Fig. 4 can be consulted in the full version, doi:10.1016/j.medin.2012.02.007).</p></span></span><span id="sec0215" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">In what high-risk surgical patients should we consider the preoperative use of an intraaortic counterpulsation balloon pump?</span><span id="sec0220" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Recommendation</span><p id="par0485" class="elsevierStylePara elsevierViewall">An IABP is advised in the preoperative phase of HS when the patient presents the following clinical and/or anatomical criteria (2C).</p></span><span id="sec0225" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">When meeting at least two of the following criteria</span><p id="par0490" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0055"><li class="elsevierStyleListItem" id="lsti0180"><span class="elsevierStyleLabel">•</span><p id="par0495" class="elsevierStylePara elsevierViewall">Left ventricle ejection fraction (LVEF)<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.40–0.35</p></li><li class="elsevierStyleListItem" id="lsti0185"><span class="elsevierStyleLabel">•</span><p id="par0500" class="elsevierStylePara elsevierViewall">Lesion of the left common trunk (LCT)<span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>70%</p></li><li class="elsevierStyleListItem" id="lsti0190"><span class="elsevierStyleLabel">•</span><p id="par0505" class="elsevierStylePara elsevierViewall">Unstable angina</p></li><li class="elsevierStyleListItem" id="lsti0195"><span class="elsevierStyleLabel">•</span><p id="par0510" class="elsevierStylePara elsevierViewall">Coronary reintervention</p></li></ul></p></span><span id="sec0230" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Other criteria to be considered</span><p id="par0515" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0060"><li class="elsevierStyleListItem" id="lsti0200"><span class="elsevierStyleLabel">•</span><p id="par0520" class="elsevierStylePara elsevierViewall">High risk patients (EUROSCORE<span class="elsevierStyleHsp" style=""></span>≥<span class="elsevierStyleHsp" style=""></span>6)</p></li><li class="elsevierStyleListItem" id="lsti0205"><span class="elsevierStyleLabel">•</span><p id="par0525" class="elsevierStylePara elsevierViewall">Hemodynamic instability</p></li><li class="elsevierStyleListItem" id="lsti0210"><span class="elsevierStyleLabel">•</span><p id="par0530" class="elsevierStylePara elsevierViewall">Emergent surgery after failed percutaneous coronary intervention (PCI) (<6<span class="elsevierStyleHsp" style=""></span>h)</p></li><li class="elsevierStyleListItem" id="lsti0215"><span class="elsevierStyleLabel">•</span><p id="par0535" class="elsevierStylePara elsevierViewall">Myocardial revascularization in the presence of ventricular aneurysms or combined with ventricular reconstruction surgery (aneurysmectomy, aneurysmoplasty)</p></li></ul></p></span></span><span id="sec0235" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">When is an intraaortic counterpulsation balloon pump indicated in the intra- or postoperative phase?</span><span id="sec0240" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Recommendation</span><p id="par0540" class="elsevierStylePara elsevierViewall">An IABP is recommended in patients who cannot be weaned from ECC after one or several attempts, or in the patients who develop LCOS or CS in the immediate PHS, refractory to adequate conventional management (1C).</p><p id="par0545" class="elsevierStylePara elsevierViewall">There are many circumstances in which an adequate level of recommendation cannot be established due to a lack of evidence. However, it may be interesting from the practical perspective to evaluate some recommendations made by experts:</p><span id="sec0245" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">In the case of predominant right ventricle failure: Is an intraaortic counterpulsation balloon pump indicated?</span><p id="par0550" class="elsevierStylePara elsevierViewall">The indication in this case is subject to important controversy,<a class="elsevierStyleCrossRefs" href="#bib0420"><span class="elsevierStyleSup">84,85</span></a> though there are experiences that report an increase in CI and mean blood pressure (MBP) within one hour after insertion, and with a high disconnection (75%) and hospital survival rate (69%). This benefit has been related to the diastolic increase in blood flow to the right coronary artery, which may improve ventricle function, and to the reduction in systemic vascular resistance which can indirectly increase the contractile capacity of the right ventricle.<a class="elsevierStyleCrossRef" href="#bib0430"><span class="elsevierStyleSup">86</span></a></p></span><span id="sec0250" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">When should we switch to another type of ventricular assist device? or When should we no longer continue with the therapeutic effort?</span><p id="par0555" class="elsevierStylePara elsevierViewall">There are a series of useful prognostic scales or clinical and biochemical markers allowing us to predict the success or failure of IABP on an early basis. In this sense, Boeken et al.<a class="elsevierStyleCrossRef" href="#bib0420"><span class="elsevierStyleSup">84</span></a> described different factors indicative of a poor course, while according to the prognostic scale developed by Haussmann,<a class="elsevierStyleCrossRef" href="#bib0435"><span class="elsevierStyleSup">87</span></a> patients with higher scores should be regarded as candidates for early ventricular assist measures.</p></span></span></span><span id="sec0255" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">When is an intraaortic counterpulsation balloon pump contraindicated in the heart surgery patient?</span><span id="sec0260" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Recommendation</span><p id="par0560" class="elsevierStylePara elsevierViewall">The following are regarded as absolute contraindications (1D):<ul class="elsevierStyleList" id="lis0065"><li class="elsevierStyleListItem" id="lsti0220"><span class="elsevierStyleLabel">-</span><p id="par0565" class="elsevierStylePara elsevierViewall">Moderate to severe aortic valve insufficiency</p></li><li class="elsevierStyleListItem" id="lsti0225"><span class="elsevierStyleLabel">-</span><p id="par0570" class="elsevierStylePara elsevierViewall">Aortic dissection</p></li><li class="elsevierStyleListItem" id="lsti0230"><span class="elsevierStyleLabel">-</span><p id="par0575" class="elsevierStylePara elsevierViewall">Bilateral femoropopliteal or iliofemoral bypass (percutaneous IABP)</p></li></ul></p><p id="par0580" class="elsevierStylePara elsevierViewall">It use and potential benefits should be carefully evaluated in patients at risk of suffering complications:<ul class="elsevierStyleList" id="lis0070"><li class="elsevierStyleListItem" id="lsti0235"><span class="elsevierStyleLabel">-</span><p id="par0585" class="elsevierStylePara elsevierViewall">Abdominal aortic aneurysm</p></li><li class="elsevierStyleListItem" id="lsti0240"><span class="elsevierStyleLabel">-</span><p id="par0590" class="elsevierStylePara elsevierViewall">Severe aortoiliac or femoral disease</p></li><li class="elsevierStyleListItem" id="lsti0245"><span class="elsevierStyleLabel">-</span><p id="par0595" class="elsevierStylePara elsevierViewall">Previous aortofemoral bypass</p></li><li class="elsevierStyleListItem" id="lsti0250"><span class="elsevierStyleLabel">-</span><p id="par0600" class="elsevierStylePara elsevierViewall">Severe coagulation disorders</p></li><li class="elsevierStyleListItem" id="lsti0255"><span class="elsevierStyleLabel">-</span><p id="par0605" class="elsevierStylePara elsevierViewall">Absence of definitive treatment for underlying diseases</p></li><li class="elsevierStyleListItem" id="lsti0260"><span class="elsevierStyleLabel">-</span><p id="par0610" class="elsevierStylePara elsevierViewall">Multiorgan failure associated to CS and/or sepsis.<a class="elsevierStyleCrossRef" href="#bib0440"><span class="elsevierStyleSup">88</span></a></p></li></ul></p></span></span><span id="sec0265" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Which patients could be candidates for mechanical circulatory assist measures in the postoperative period of heart surgery?</span><span id="sec0270" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Recommendation</span><p id="par0615" class="elsevierStylePara elsevierViewall">Mechanical circulatory assist devices are recommended in heart surgery patients in which:<ul class="elsevierStyleList" id="lis0075"><li class="elsevierStyleListItem" id="lsti0265"><span class="elsevierStyleLabel">∘</span><p id="par0620" class="elsevierStylePara elsevierViewall">In the operating room: weaning from ECC is not possible, despite adequate surgical correction.</p></li><li class="elsevierStyleListItem" id="lsti0270"><span class="elsevierStyleLabel">∘</span><p id="par0625" class="elsevierStylePara elsevierViewall">In the PHS: the patient develops criteria of CS in the immediate postoperative period.</p></li></ul></p><p id="par0630" class="elsevierStylePara elsevierViewall">In any of the situations: patients refractory to maximum pharmacological circulatory support (with at least 2 vasoactive drugs) and/or IABP, and who present no contraindications to implantation (1C).</p></span></span><span id="sec0275" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Which patients with postcardiotomy shock should not receive circulatory assist devices?</span><span id="sec0280" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Recommendation</span><p id="par0635" class="elsevierStylePara elsevierViewall">A circulatory assist device should not be implanted in the absence or lack of indication criteria. In many cases the contraindication is not absolute; as a result, evaluation is required of the possible general and relative contraindications in each concrete case—with individualized assessment of the possible benefits as weighed against the potential complications (1D).</p></span></span><span id="sec0285" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Which patients could be candidates for heart transplantation in LCOS in the postoperative period of heart surgery?</span><span id="sec0290" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Recommendation</span><p id="par0640" class="elsevierStylePara elsevierViewall">Possible candidates for heart transplantation are patients who after heart surgery:<ul class="elsevierStyleList" id="lis0080"><li class="elsevierStyleListItem" id="lsti0275"><span class="elsevierStyleLabel">-</span><p id="par0645" class="elsevierStylePara elsevierViewall">Suffer CS refractory to treatment, including mechanical support (IABP and/or ventricular assist), or have confirmed dependency upon intravenous inotropic support in order to maintain adequate organ perfusion.</p></li><li class="elsevierStyleListItem" id="lsti0280"><span class="elsevierStyleLabel">-</span><p id="par0650" class="elsevierStylePara elsevierViewall">Present irreversible hemodynamic conditions.</p></li><li class="elsevierStyleListItem" id="lsti0285"><span class="elsevierStyleLabel">-</span><p id="par0655" class="elsevierStylePara elsevierViewall">Present no contraindication, with non-reversible multiple organ involvement (2D).</p></li></ul></p></span></span><span id="sec0295" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">In which patients are renal replacement therapy recommended, and which modality should be used in postcardiotomy low cardiac output syndrome?</span><span id="sec0300" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Recommendation</span><p id="par0660" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0085"><li class="elsevierStyleListItem" id="lsti0290"><span class="elsevierStyleLabel">•</span><p id="par0665" class="elsevierStylePara elsevierViewall">In patients who develop acute renal failure according to the Risk, Injury, Failure, Loss of kidney function, and End-stage renal failure/Acute Kidney Injury Network (RIFLE/AKIN) criteria, with due clinical evaluation of the patient (1C).</p></li><li class="elsevierStyleListItem" id="lsti0295"><span class="elsevierStyleLabel">•</span><p id="par0670" class="elsevierStylePara elsevierViewall">These techniques are advised in patients with fluid overload and for correcting hyponatremia, in patients refractory to diuretics (1C).</p></li></ul></p></span></span><span id="sec0305" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">What is the correct moment for starting such therapy in patients with low cardiac output syndrome?</span><span id="sec0310" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Recommendation</span><p id="par0675" class="elsevierStylePara elsevierViewall">No universal recommendation can be made regarding the promptness of use in LCOS during the PHS. The decision depends on clinical and logistic criteria (2D).</p></span></span><span id="sec0315" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Conflicts of interest</span><p id="par0680" class="elsevierStylePara elsevierViewall">The authors declare no conflicts of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:36 [ 0 => array:2 [ "identificador" => "xres9068" "titulo" => "Abstract" ] 1 => array:2 [ "identificador" => "xpalclavsec10507" "titulo" => "Keywords" ] 2 => array:2 [ "identificador" => "xres9067" "titulo" => "Resumen" ] 3 => array:2 [ "identificador" => "xpalclavsec10508" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Concept" ] 5 => array:2 [ "identificador" => "sec0010" "titulo" => "Objectives of the guide" ] 6 => array:2 [ "identificador" => "sec0015" "titulo" => "Scope of the guide" ] 7 => array:2 [ "identificador" => "sec0020" "titulo" => "Limitations of the guide" ] 8 => array:2 [ "identificador" => "sec0025" "titulo" => "Users" ] 9 => array:3 [ "identificador" => "sec0030" "titulo" => "Methodology for development of the guide" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "sec0035" "titulo" => "Conformation of the group" ] 1 => array:2 [ "identificador" => "sec0040" "titulo" => "Biomedical literature search and development of the guide" ] 2 => array:2 [ "identificador" => "sec0045" "titulo" => "Updating of the guide" ] 3 => array:2 [ "identificador" => "sec0050" "titulo" => "Exoneration" ] ] ] 10 => array:3 [ "identificador" => "sec0055" "titulo" => "How could we define low cardiac output syndrome in the postoperative period of heart surgery?" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0060" "titulo" => "Recommendation" ] ] ] 11 => array:3 [ "identificador" => "sec0065" "titulo" => "Is low cardiac output syndrome acute heart failure?" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0070" "titulo" => "Recommendation" ] ] ] 12 => array:3 [ "identificador" => "sec0075" "titulo" => "Can we identify risk factors for the development of low cardiac output syndrome?" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0080" "titulo" => "Recommendation" ] ] ] 13 => array:3 [ "identificador" => "sec0085" "titulo" => "What are the basic monitorization needs in the postoperative period of heart surgery?" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0090" "titulo" => "Recommendations" ] ] ] 14 => array:3 [ "identificador" => "sec0095" "titulo" => "In which patients should advanced hemodynamic monitorization be considered?" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0100" "titulo" => "Recommendation" ] ] ] 15 => array:3 [ "identificador" => "sec0105" "titulo" => "How can we estimate preload?" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0110" "titulo" => "Recommendations" ] ] ] 16 => array:3 [ "identificador" => "sec0115" "titulo" => "In which patients should we know cardiac output in the postoperative period of heart surgery?" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0120" "titulo" => "Recommendations" ] ] ] 17 => array:3 [ "identificador" => "sec0125" "titulo" => "What role does the echocardiogram play in the postoperative period of heart surgery?" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0130" "titulo" => "Recommendations" ] ] ] 18 => array:3 [ "identificador" => "sec0135" "titulo" => "Should venous oxygen saturation be determined?" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0140" "titulo" => "Recommendation" ] ] ] 19 => array:3 [ "identificador" => "sec0145" "titulo" => "Should we determine lactate in the postoperative period of heart surgery?" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0150" "titulo" => "Recommendations" ] ] ] 20 => array:3 [ "identificador" => "sec0155" "titulo" => "What are the general hemodynamic objectives in the management of a patient with low cardiac output syndrome?" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0160" "titulo" => "Recommendation" ] ] ] 21 => array:3 [ "identificador" => "sec0165" "titulo" => "Is it important to control heart rate and cardiac rhythm? How should arrhythmias be dealt with?" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0170" "titulo" => "Recommendation" ] ] ] 22 => array:3 [ "identificador" => "sec0175" "titulo" => "From what hemoglobin levels do these patients require transfusion?" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0180" "titulo" => "Recommendation" ] ] ] 23 => array:3 [ "identificador" => "sec0185" "titulo" => "What inotropic drugs and vasopressors may be useful in the management of low cardiac output syndrome? Is there any “best” option?" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0190" "titulo" => "Recommendations" ] ] ] 24 => array:3 [ "identificador" => "sec0195" "titulo" => "Algorithm for the management of predominant left ventricle failure" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0200" "titulo" => "Recommendation" ] ] ] 25 => array:3 [ "identificador" => "sec0205" "titulo" => "Algorithm for the management of predominant right ventricle failure" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0210" "titulo" => "Recommendation" ] ] ] 26 => array:3 [ "identificador" => "sec0215" "titulo" => "In what high-risk surgical patients should we consider the preoperative use of an intraaortic counterpulsation balloon pump?" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0220" "titulo" => "Recommendation" ] 1 => array:2 [ "identificador" => "sec0225" "titulo" => "When meeting at least two of the following criteria" ] 2 => array:2 [ "identificador" => "sec0230" "titulo" => "Other criteria to be considered" ] ] ] 27 => array:3 [ "identificador" => "sec0235" "titulo" => "When is an intraaortic counterpulsation balloon pump indicated in the intra- or postoperative phase?" "secciones" => array:1 [ 0 => array:3 [ "identificador" => "sec0240" "titulo" => "Recommendation" "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0245" "titulo" => "In the case of predominant right ventricle failure: Is an intraaortic counterpulsation balloon pump indicated?" ] 1 => array:2 [ "identificador" => "sec0250" "titulo" => "When should we switch to another type of ventricular assist device? or When should we no longer continue with the therapeutic effort?" ] ] ] ] ] 28 => array:3 [ "identificador" => "sec0255" "titulo" => "When is an intraaortic counterpulsation balloon pump contraindicated in the heart surgery patient?" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0260" "titulo" => "Recommendation" ] ] ] 29 => array:3 [ "identificador" => "sec0265" "titulo" => "Which patients could be candidates for mechanical circulatory assist measures in the postoperative period of heart surgery?" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0270" "titulo" => "Recommendation" ] ] ] 30 => array:3 [ "identificador" => "sec0275" "titulo" => "Which patients with postcardiotomy shock should not receive circulatory assist devices?" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0280" "titulo" => "Recommendation" ] ] ] 31 => array:3 [ "identificador" => "sec0285" "titulo" => "Which patients could be candidates for heart transplantation in LCOS in the postoperative period of heart surgery?" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0290" "titulo" => "Recommendation" ] ] ] 32 => array:3 [ "identificador" => "sec0295" "titulo" => "In which patients are renal replacement therapy recommended, and which modality should be used in postcardiotomy low cardiac output syndrome?" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0300" "titulo" => "Recommendation" ] ] ] 33 => array:3 [ "identificador" => "sec0305" "titulo" => "What is the correct moment for starting such therapy in patients with low cardiac output syndrome?" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0310" "titulo" => "Recommendation" ] ] ] 34 => array:2 [ "identificador" => "sec0315" "titulo" => "Conflicts of interest" ] 35 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2011-11-03" "fechaAceptado" => "2012-01-07" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec10507" "palabras" => array:4 [ 0 => "Low cardiac output syndrome" 1 => "Ventricular failure" 2 => "Cardiac surgery" 3 => "GRADE methodology" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec10508" "palabras" => array:4 [ 0 => "Síndrome de bajo gasto cardiaco" 1 => "Fracaso ventricular" 2 => "Cirugía cardiaca" 3 => "Metodología GRADE" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Low cardiac output syndrome (LCOS) is a potential complication in cardiac surgery patients and is associated with increased morbidity and mortality. This guide provides recommendations for the management of these patients, immediately after surgery and following admission to the Intensive Care Unit (ICU). The recommendations are grouped into different sections, addressing from the most basic concepts such as definition of the disorder to the different sections of basic and advanced monitoring, and culminating with the complex management of this syndrome. We propose an algorithm for initial management, as well as two others for ventricular failure (predominantly left or right). Most of the recommendations are based on expert consensus, due to the lack of randomized trials of adequate design and sample size in patients of this kind. The quality of evidence and strength of the recommendations were based on the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology. The guide is presented as a list of recommendations (with the level of evidence for each recommendation) for each question on the selected topic. For each question, justification of the recommendations is then provided.</p>" ] "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">El síndrome de bajo gasto cardiaco es una potencial complicación de los pacientes intervenidos de cirugía cardiaca y asocia un aumento de la morbimortalidad. La presente guía pretende proporcionar recomendaciones para el manejo de estos pacientes, en el postoperatorio inmediato, ingresados en UCI. Las recomendaciones se han agrupado en diferentes apartados, tratando de dar respuesta desde los conceptos más básicos como es la definición a los diferentes apartados de monitorización básica y avanzada, y terminando con el complejo manejo de este síndrome. Se propone un algoritmo de manejo inicial, así como otros de fracaso ventricular predominantemente izquierdo o derecho. La mayor parte de las recomendaciones están basadas en el consenso de expertos, debido a la falta de estudios clínicos aleatorizados, de adecuado diseño y tamaño muestral en este grupo de pacientes. La calidad de la evidencia y la fuerza de las recomendaciones se realizó siguiendo la metodología GRADE. La guía se presenta como una lista de recomendaciones (y nivel de evidencia de cada recomendación) para cada pregunta del tema seleccionado. A continuación, en cada pregunta, se procede a la justificación de las recomendaciones.</p>" ] ] "NotaPie" => array:2 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara">Please cite this article as: Pérez Vela E, et al. Resumen del documento de consenso «Guías de práctica clínica para el manejo del síndrome de bajo gasto cardiaco en el postoperatorio de cirugía cardiaca». Med Intensiva. 2012;36:277–87.</p>" ] 1 => array:2 [ "etiqueta" => "☆☆" "nota" => "<p class="elsevierStyleNotepara">The full version of this consensus document is published in <span class="elsevierStyleItalic">Medicina Intensiva</span> 2012. doi:10.1016/j.medin.2012.02.007. Available from: <span class="elsevierStyleInterRef" href="http://www.elsevier.es/medicina-intensiva">www.elsevier.es/medicina-intensiva</span>.</p>" ] ] "nomenclatura" => array:1 [ 0 => array:1 [ "listaDefinicion" => array:1 [ 0 => array:2 [ "titulo" => "<span class="elsevierStyleSectionTitle">Glossary of abbreviations and terms</span>" "definicion" => array:29 [ 0 => array:2 [ "termino" => "ACC/AHA" "descripcion" => "<p id="par0005" class="elsevierStylePara elsevierViewall">American College of Cardiology/American Heart Association</p>" ] 1 => array:2 [ "termino" => "IABP" "descripcion" => "<p id="par0010" class="elsevierStylePara elsevierViewall">intraaortic counterpulsation balloon pump</p>" ] 2 => array:2 [ "termino" => "PAC" "descripcion" => "<p id="par0015" class="elsevierStylePara elsevierViewall">pulmonary artery catheter</p>" ] 3 => array:2 [ "termino" => "HS" "descripcion" => "<p id="par0020" class="elsevierStylePara elsevierViewall">heart surgery</p>" ] 4 => array:2 [ "termino" => "ECC" "descripcion" => "<p id="par0025" class="elsevierStylePara elsevierViewall">extracorporeal circulation</p>" ] 5 => array:2 [ "termino" => "EG" "descripcion" => "<p id="par0030" class="elsevierStylePara elsevierViewall">echocardiogram</p>" ] 6 => array:2 [ "termino" => "ESC" "descripcion" => "<p id="par0035" class="elsevierStylePara elsevierViewall">European Society of Cardiology</p>" ] 7 => array:2 [ "termino" => "TEE" "descripcion" => "<p id="par0040" class="elsevierStylePara elsevierViewall">transesophageal echocardiogram</p>" ] 8 => array:2 [ "termino" => "TTE" "descripcion" => "<p id="par0045" class="elsevierStylePara elsevierViewall">transthoracic echocardiogram</p>" ] 9 => array:2 [ "termino" => "LVEF" "descripcion" => "<p id="par0050" class="elsevierStylePara elsevierViewall">left ventricle ejection fraction</p>" ] 10 => array:2 [ "termino" => "CO" "descripcion" => "<p id="par0055" class="elsevierStylePara elsevierViewall">cardiac output</p>" ] 11 => array:2 [ "termino" => "GRADE" "descripcion" => "<p id="par0060" class="elsevierStylePara elsevierViewall">Grading of Recommendations Assessment, Development and Evaluation (working group)</p>" ] 12 => array:2 [ "termino" => "PHT" "descripcion" => "<p id="par0065" class="elsevierStylePara elsevierViewall">pulmonary hypertension</p>" ] 13 => array:2 [ "termino" => "CI" "descripcion" => "<p id="par0070" class="elsevierStylePara elsevierViewall">cardiac index</p>" ] 14 => array:2 [ "termino" => "AHF" "descripcion" => "<p id="par0075" class="elsevierStylePara elsevierViewall">acute heart failure</p>" ] 15 => array:2 [ "termino" => "PCI" "descripcion" => "<p id="par0080" class="elsevierStylePara elsevierViewall">percutaneous coronary intervention</p>" ] 16 => array:2 [ "termino" => "CVP" "descripcion" => "<p id="par0085" class="elsevierStylePara elsevierViewall">central venous pressure</p>" ] 17 => array:2 [ "termino" => "RIFLE/AKIN" "descripcion" => "<p id="par0090" class="elsevierStylePara elsevierViewall">Risk, Injury, Failure, Loss of kidney function, and End-stage renal failure/Acute Kidney Injury Network</p>" ] 18 => array:2 [ "termino" => "LCOS" "descripcion" => "<p id="par0095" class="elsevierStylePara elsevierViewall">postoperative low cardiac output syndrome (in heart surgery)</p>" ] 19 => array:2 [ "termino" => "CS" "descripcion" => "<p id="par0100" class="elsevierStylePara elsevierViewall">cardiogenic shock</p>" ] 20 => array:2 [ "termino" => "SEMICYUC" "descripcion" => "<p id="par0105" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Sociedad Española de Medicina Intensiva, Critica y Unidades Coronarias</span></p>" ] 21 => array:2 [ "termino" => "ALS" "descripcion" => "<p id="par0110" class="elsevierStylePara elsevierViewall">advanced life support</p>" ] 22 => array:2 [ "termino" => "ScvO<span class="elsevierStyleInf">2</span>" "descripcion" => "<p id="par0115" class="elsevierStylePara elsevierViewall">central venous oxygen saturation</p>" ] 23 => array:2 [ "termino" => "SvO<span class="elsevierStyleInf">2</span>" "descripcion" => "<p id="par0120" class="elsevierStylePara elsevierViewall">venous oxygen saturation</p>" ] 24 => array:2 [ "termino" => "BP" "descripcion" => "<p id="par0125" class="elsevierStylePara elsevierViewall">blood pressure</p>" ] 25 => array:2 [ "termino" => "MBP" "descripcion" => "<p id="par0130" class="elsevierStylePara elsevierViewall">mean blood pressure</p>" ] 26 => array:2 [ "termino" => "SBP" "descripcion" => "<p id="par0135" class="elsevierStylePara elsevierViewall">systolic blood pressure</p>" ] 27 => array:2 [ "termino" => "LCT" "descripcion" => "<p id="par0140" class="elsevierStylePara elsevierViewall">left common trunk</p>" ] 28 => array:2 [ "termino" => "ICU" "descripcion" => "<p id="par0145" class="elsevierStylePara elsevierViewall">Intensive Care Unit</p>" ] ] ] ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:88 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Predictors of low cardiac output syndrome after coronary artery bypass" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Thorac Cardiovasc Surg" "fecha" => "1996" "volumen" => "112" "paginaInicial" => "38" "paginaFinal" => "51" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Complicaciones hemodinámicas de la cirugía cardiaca" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:4 [ "titulo" => "Riesgo y complicaciones en Cirugía Cardiaca" "paginaInicial" => "205" "paginaFinal" => "219" "serieFecha" => "2004" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Presentation and outcome of critically ill medical and cardiac-surgery patients with acute heart failure" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "smw-12446" "Revista" => array:7 [ "tituloSerie" => "Swiss Med Wkly" "fecha" => "2009" "volumen" => "139" "paginaInicial" => "110" "paginaFinal" => "116" "link" => array:1 [ 0 => array:2 [ …2] ] "itemHostRev" => array:3 [ "pii" => "S0168822708000843" "estado" => "S300" "issn" => "01688227" ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Practical recommendations on the management of perioperative heart failure in cardiac surgery" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/cc8153" "Revista" => array:6 [ "tituloSerie" => "Crit Care" "fecha" => "2010" "volumen" => "14" "paginaInicial" => "201" "paginaFinal" => "214" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "S3 guidelines for intensive care in cardiac surgery patients: hemodynamic monitoring and cardiocirculary system" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Ger Med Sci" "fecha" => "2010" "volumen" => "8" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Grading quality of evidence and strength of recommendations" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "GRADE Working Group" "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/bmj.328.7454.1490" "Revista" => array:6 [ "tituloSerie" => "BMJ" "fecha" => "2004" "volumen" => "328" "paginaInicial" => "1490" "paginaFinal" => "1498" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "<a class="elsevierStyleInterRef" href="http://www.gradeworkinggroup.org/">http://www.gradeworkinggroup.org/</a> [accessed 09.06.10]." ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hemodynamic effects of dobutamine in patients following open heart surgery" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "1977" "volumen" => "55" "paginaInicial" => "525" "paginaFinal" => "533" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The comparative effects of dopamine and dobutamine on ventricular mechanics after coronary artery bypass grafting: a pressure-dimension analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Circulation" "fecha" => "1984" "volumen" => "70" "paginaInicial" => "1112" "paginaFinal" => "1117" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Dobutamine and dopamine after cardiac surgery: greater augmentation of myocardial blood flow with dobutamine" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Circulation" "fecha" => "1984" "volumen" => "70" "paginaInicial" => "1103" "paginaFinal" => "1111" ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Low-dose dopamine during cardiopulmonary bypass in patients with renal dysfunction" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Cardiothorac Anesth" "fecha" => "1990" "volumen" => "4" "paginaInicial" => "469" "paginaFinal" => "473" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy of the phosphodiesterase inhibitor enoximone in complicated cardiac surgery" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "1990" "volumen" => "98" "paginaInicial" => "53" "paginaFinal" => "58" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hemodynamic and metabolic effects of dobutamine in 18 patients after open heart surgery" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Crit Care Med" "fecha" => "1990" "volumen" => "18" "paginaInicial" => "1107" "paginaFinal" => "1110" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0070" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A randomized, blinded, placebo-controlled evaluation of calcium chloride and epinephrine for inotropic support after emergence from cardiopulmonary bypass" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Anesth Analg" "fecha" => "1992" "volumen" => "74" "paginaInicial" => "3" "paginaFinal" => "13" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0075" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Amrinone and dobutamine as primary treatment of low cardiac output syndrome following coronary artery surgery: a comparison of their effects on hemodynamics and outcome" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Cardiothorac Vasc Anesth" "fecha" => "1992" "volumen" => "6" "paginaInicial" => "542" "paginaFinal" => "553" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0080" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Calcium inhibits the cardiac stimulating properties of dobutamine but not of amrinone" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "1992" "volumen" => "101" "paginaInicial" => "174" "paginaFinal" => "180" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0085" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Regional blood flow and oxygen transport in patients with the low cardiac output syndrome after cardiac surgery" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Crit Care Med" "fecha" => "1993" "volumen" => "21" "paginaInicial" => "1304" "paginaFinal" => "1311" "link" => array:1 [ 0 => array:2 [ …2] ] "itemHostRev" => array:3 [ "pii" => "S0022347603003251" "estado" => "S300" "issn" => "00223476" ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0090" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Haemodynamic effects and comparison of enoximone, dobutamine and dopamine following mitral valve surgery" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Eur J Anaesthesiol Suppl" "fecha" => "1993" "volumen" => "8" "paginaInicial" => "15" "paginaFinal" => "24" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0095" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Combined inotropic effects of amrinone and epinephrine after cardiopulmonary bypass in humans" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Anesth Analg" "fecha" => "1993" "volumen" => "77" "paginaInicial" => "662" "paginaFinal" => "672" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0100" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Amrinone in cardiac surgical patients with left-ventricular dysfunction" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "1993" "volumen" => "104" "paginaInicial" => "1660" "paginaFinal" => "1667" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0105" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The efficacy of amrinone or adrenaline on low cardiac output following cardiopulmonary bypass in patients with coronary artery disease undergoing preoperative beta-blockade" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1055/s-2007-1013790" "Revista" => array:7 [ "tituloSerie" => "Thorac Cardiovasc Surg" "fecha" => "1995" "volumen" => "43" "paginaInicial" => "153" "paginaFinal" => "160" "link" => array:1 [ 0 => array:2 [ …2] ] "itemHostRev" => array:3 [ "pii" => "S0168822710005590" "estado" => "S300" "issn" => "01688227" ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0110" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A pharmacokinetic and pharmacodynamic evaluation of milrinone in adults undergoing cardiac surgery" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Anesth Analg" "fecha" => "1995" "volumen" => "81" "paginaInicial" => "783" "paginaFinal" => "792" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0115" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The effects of milrinone on platelets in patients undergoing cardiac surgery" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Anesth Analg" "fecha" => "1995" "volumen" => "81" "paginaInicial" => "44" "paginaFinal" => "48" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0120" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The effect of milrinone on hemodynamics and left ventricular function after emergence from cardiopulmonary bypass" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Anesth Analg" "fecha" => "1997" "volumen" => "85" "paginaInicial" => "16" "paginaFinal" => "22" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0125" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Postcardiac surgery low cardiac output syndrome: dopexamine or dopamine?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Intensive Care Med" "fecha" => "1997" "volumen" => "23" "paginaInicial" => "962" "paginaFinal" => "968" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0130" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of dopexamine on creatinine clearance, systemic inflammation, and splanchnic oxygenation in patients undergoing coronary artery bypass grafting" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Anesth Analg" "fecha" => "1997" "volumen" => "84" "paginaInicial" => "950" "paginaFinal" => "957" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0135" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cardiopulmonary effects of enoximone or dobutamine and nitroglycerin on mitral valve regurgitation and pulmonary venous hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Cardiothorac Vasc Anesth" "fecha" => "1997" "volumen" => "11" "paginaInicial" => "453" "paginaFinal" => "457" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0140" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epinephrine-induced lactic acidosis following cardiopulmonary bypass" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Crit Care Med" "fecha" => "1997" "volumen" => "25" "paginaInicial" => "1693" "paginaFinal" => "1699" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0145" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Amrinone versus dobutamine in cardiac surgical patients with severe pulmonary hypertension after cardiopulmonary bypass: a prospective, randomized double-blinded trial" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Anaesth Intensive care" "fecha" => "1997" "volumen" => "25" "paginaInicial" => "245" "paginaFinal" => "249" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0150" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A placebo-controlled trial verifying the efficacy of milrinone in weaning high-risk patients from cardiopulmonary bypass" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Cardiothorac Vasc Anesth" "fecha" => "1997" "volumen" => "11" "paginaInicial" => "37" "paginaFinal" => "41" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0155" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A single dose of milrinone facilitates separation from cardiopulmonary bypass in patients with pre-existing left ventricular dysfunction" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Br J Anaesth" "fecha" => "1998" "volumen" => "81" "paginaInicial" => "782" "paginaFinal" => "784" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0160" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A bolus dose of 1.5<span class="elsevierStyleHsp" style=""></span>mg/kg amrinone effectively improves low cardiac output state following separation from cardiopulmonary bypass in cardiac surgical patients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Acta Anesth Scand" "fecha" => "1998" "volumen" => "42" "paginaInicial" => "825" "paginaFinal" => "833" ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib0165" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Factors that predict the use of positive inotropic drug support after cardiac valve surgery" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Anesth Analg" "fecha" => "1998" "volumen" => "86" "paginaInicial" => "461" "paginaFinal" => "467" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0170" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A multicenter, randomized, blind comparison of amrinone with milrinone after elective cardiac surgery" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Anesth Analg" "fecha" => "1998" "volumen" => "86" "paginaInicial" => "683" "paginaFinal" => "690" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0175" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of a new calcium sensitizer, levosimendan, on hemodynamics, coronary blood flow and myocardial substrate utilization early after CABG" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Eur Heart J" "fecha" => "1998" "volumen" => "19" "paginaInicial" => "660" "paginaFinal" => "668" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib0180" "etiqueta" => "36" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of dobutamine on hemodynamics and left ventricular performance after cardiopulmonary bypass in cardiac surgical patients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Anesthesiology" "fecha" => "1999" "volumen" => "91" "paginaInicial" => "1318" "paginaFinal" => "1328" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib0185" "etiqueta" => "37" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Differential effects of dopamine, dopexamine, and dobutamine on jejunal mucosal perfusion early after cardiac surgery" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Crit Care Med" "fecha" => "2000" "volumen" => "28" "paginaInicial" => "2338" "paginaFinal" => "2343" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib0190" "etiqueta" => "38" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hemodynamic effects of milrinone during weaning from cardiopulmonary bypass: comparison of patients with a low and high prebypass cardiac index" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/jcan.2000.7920" "Revista" => array:6 [ "tituloSerie" => "J Cardiothorac Vasc Anesth" "fecha" => "2000" "volumen" => "14" "paginaInicial" => "367" "paginaFinal" => "373" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 38 => array:3 [ "identificador" => "bib0195" "etiqueta" => "39" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "European Milrinone Multicenter Trial Group" "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/jcan.2001.23274" "Revista" => array:6 [ "tituloSerie" => "J Cardiothorac Vasc Anesth" "fecha" => "2001" "volumen" => "15" "paginaInicial" => "306" "paginaFinal" => "315" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 39 => array:3 [ "identificador" => "bib0200" "etiqueta" => "40" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The efficacy of preemptive milrinone or amrinone therapy in patients undergoing coronary artery bypass grafting" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Anesth Analg" "fecha" => "2002" "volumen" => "94" "paginaInicial" => "22" "paginaFinal" => "30" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 40 => array:3 [ "identificador" => "bib0205" "etiqueta" => "41" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Sustained hemodynamic effects of intravenous levosimendan" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "2003" "volumen" => "107" "paginaInicial" => "81" "paginaFinal" => "86" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 41 => array:3 [ "identificador" => "bib0210" "etiqueta" => "42" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of levosimendan on restrictive left ventricular filling in severe heart failure: a combined hemodynamic and Doppler echocardiographic study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1378/chest.128.4.2633" "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "2005" "volumen" => "128" "paginaInicial" => "2633" "paginaFinal" => "2639" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 42 => array:3 [ "identificador" => "bib0215" "etiqueta" => "43" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparación de los efectos hemodinámicos del levosimendán con la dobutamina en los pacientes con bajo gasto cardiaco después de cirugía cardiaca" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Rev Esp cardiol" "fecha" => "2006" "volumen" => "59" "paginaInicial" => "338" "paginaFinal" => "345" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 43 => array:3 [ "identificador" => "bib0220" "etiqueta" => "44" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Preconditioning effects of levosimendan in coronary artery bypass grafting—a pilot study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/bja/ael082" "Revista" => array:6 [ "tituloSerie" => "Br J Anaesth" "fecha" => "2006" "volumen" => "96" "paginaInicial" => "694" "paginaFinal" => "700" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 44 => array:3 [ "identificador" => "bib0225" "etiqueta" => "45" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Levosimendan or milrinone in the type 2 diabetic patient with low ejection fraction undergoing elective coronary artery surgery" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/j.jvca.2006.02.012" "Revista" => array:6 [ "tituloSerie" => "J Cardiothorac Vasc Anesth" "fecha" => "2006" "volumen" => "20" "paginaInicial" => "353" "paginaFinal" => "357" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 45 => array:3 [ "identificador" => "bib0230" "etiqueta" => "46" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy and safety of perioperative infusion of levosimendan in patients with compromised cardiac function undergoing open-heart surgery: importance of early use" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ejcts.2007.07.010" "Revista" => array:6 [ "tituloSerie" => "Eur J Cardiothorac Surg" "fecha" => "2007" "volumen" => "32" "paginaInicial" => "629" "paginaFinal" => "633" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 46 => array:3 [ "identificador" => "bib0235" "etiqueta" => "47" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The effects of levosimendan in cardiac surgery patients with poor left ventricular function" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1213/01.ane.0000256863.92050.d3" "Revista" => array:6 [ "tituloSerie" => "Anesth Analg" "fecha" => "2007" "volumen" => "104" "paginaInicial" => "766" "paginaFinal" => "773" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 47 => array:3 [ "identificador" => "bib0240" "etiqueta" => "48" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The metabolic and renal effects of adrenaline and milrinone in patients with myocardial dysfunction after coronary artery bypass grafting" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/cc5904" "Revista" => array:5 [ "tituloSerie" => "Crit Care" "fecha" => "2007" "volumen" => "11" "paginaInicial" => "R51" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 48 => array:3 [ "identificador" => "bib0245" "etiqueta" => "49" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A randomized trial evaluating different modalities of levosimendan administration in cardiac surgery patients with myocardial dysfunction" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/j.jvca.2008.02.019" "Revista" => array:6 [ "tituloSerie" => "J Cardiothorac Vasc Anesth" "fecha" => "2008" "volumen" => "22" "paginaInicial" => "699" "paginaFinal" => "705" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 49 => array:3 [ "identificador" => "bib0250" "etiqueta" => "50" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Eur J Med Res" "fecha" => "2008" "volumen" => "13" "paginaInicial" => "459" "paginaFinal" => "463" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 50 => array:3 [ "identificador" => "bib0255" "etiqueta" => "51" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Levosimendan in aortic valve surgery: cardiac performance and recovery" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/j.jvca.2008.01.024" "Revista" => array:6 [ "tituloSerie" => "J Cardiothorac Vasc Anesth" "fecha" => "2008" "volumen" => "22" "paginaInicial" => "693" "paginaFinal" => "698" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 51 => array:3 [ "identificador" => "bib0260" "etiqueta" => "52" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Superioridad del sensibilizante al calcio levosimendan comparado con dobutamina en el síndrome de bajo gasto cardiaco postoperatorio" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Rev Esp Cardiol" "fecha" => "2008" "volumen" => "61" "paginaInicial" => "471" "paginaFinal" => "479" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 52 => array:3 [ "identificador" => "bib0265" "etiqueta" => "53" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery" "autores" => array:1 [ 0 => array:2 [ "etal" => true …1 ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/bja/aen367" "Revista" => array:6 [ "tituloSerie" => "Br J Anaesth" "fecha" => "2009" "volumen" => "102" "paginaInicial" => "198" "paginaFinal" => "204" "link" => array:1 [ …1] ] ] ] ] ] ] 53 => array:3 [ "identificador" => "bib0270" "etiqueta" => "54" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Levosimendan reduces cardiac troponin release after cardiac surgery: a meta-analysis of randomized controlled studies" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/j.jvca.2008.11.013" "Revista" => array:6 [ "tituloSerie" => "J Cardiothorac Vasc Anesth" "fecha" => "2009" "volumen" => "23" "paginaInicial" => "474" "paginaFinal" => "478" "link" => array:1 [ …1] ] ] ] ] ] ] 54 => array:3 [ "identificador" => "bib0275" "etiqueta" => "55" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.athoracsur.2008.10.029" "Revista" => array:6 [ "tituloSerie" => "Ann Thorac Surg" "fecha" => "2009" "volumen" => "87" "paginaInicial" => "448" "paginaFinal" => "454" "link" => array:1 [ …1] ] ] ] ] ] ] 55 => array:3 [ "identificador" => "bib0280" "etiqueta" => "56" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A retrospective analysis of terlipressin in bolus for the management of refractory vasoplegic hypotension after cardiac surgery" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1510/icvts.2009.209890" "Revista" => array:6 [ "tituloSerie" => "Interact Cardiovasc Thorac Surg" "fecha" => "2009" "volumen" => "9" "paginaInicial" => "588" "paginaFinal" => "592" "link" => array:1 [ …1] ] ] ] ] ] ] 56 => array:3 [ "identificador" => "bib0285" "etiqueta" => "57" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Reducing mortality in cardiac surgery with levosimendan: a meta-analysis of randomized controlled trials" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/j.jvca.2009.05.031" "Revista" => array:6 [ "tituloSerie" => "J Cardiothorac Vasc Anesth" "fecha" => "2010" "volumen" => "24" "paginaInicial" => "51" "paginaFinal" => "57" "link" => array:1 [ …1] ] ] ] ] ] ] 57 => array:3 [ "identificador" => "bib0290" "etiqueta" => "58" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of fenoldopam infusion in complex cardiac surgical operations: a prospective, randomized, double-blind, placebo-controlled study" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Minerva Anestesiol" "fecha" => "2010" "volumen" => "76" "paginaInicial" => "249" "paginaFinal" => "259" "link" => array:1 [ …1] ] ] ] ] ] ] 58 => array:3 [ "identificador" => "bib0295" "etiqueta" => "59" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acute hemodynamic effects of dopamine in patients with shock" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "1971" "volumen" => "44" "paginaInicial" => "163" "paginaFinal" => "173" "link" => array:1 [ …1] ] ] ] ] ] ] 59 => array:3 [ "identificador" => "bib0300" "etiqueta" => "60" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Circulation" "fecha" => "1977" "volumen" => "56" "paginaInicial" => "468" "paginaFinal" => "472" "link" => array:1 [ …1] "itemHostRev" => array:3 [ …3] ] ] ] ] ] ] 60 => array:3 [ "identificador" => "bib0305" "etiqueta" => "61" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "1977" "volumen" => "55" "paginaInicial" => "375" "paginaFinal" => "381" "link" => array:1 [ …1] ] ] ] ] ] ] 61 => array:3 [ "identificador" => "bib0310" "etiqueta" => "62" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evaluation of a new bipyridine inotropic agent-milrinone-in patients with severe congestive heart failure" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM198309293091302" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "1983" "volumen" => "309" "paginaInicial" => "748" "paginaFinal" => "756" "link" => array:1 [ …1] ] ] ] ] ] ] 62 => array:3 [ "identificador" => "bib0315" "etiqueta" => "63" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "1984" "volumen" => "70" "paginaInicial" => "1038" "paginaFinal" => "1047" "link" => array:1 [ …1] ] ] ] ] ] ] 63 => array:3 [ "identificador" => "bib0320" "etiqueta" => "64" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: a multicenter study" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "JACC" "fecha" => "1987" "volumen" => "9" "paginaInicial" => "711" "paginaFinal" => "722" "link" => array:1 [ …1] "itemHostRev" => array:3 [ …3] ] ] ] ] ] ] 64 => array:3 [ "identificador" => "bib0325" "etiqueta" => "65" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Central and regional hemodynamic effects of oral enoximone in congestive heart failure: a double-blind, placebo-controlled study" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am Heart J" "fecha" => "1988" "volumen" => "115" "paginaInicial" => "1051" "paginaFinal" => "1059" "link" => array:1 [ …1] ] ] ] ] ] ] 65 => array:3 [ "identificador" => "bib0330" "etiqueta" => "66" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A comparison of oral milrinone digoxin, and their combination in the treatment of patients with chronic heart failure" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM198903163201101" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "1989" "volumen" => "320" "paginaInicial" => "677" "paginaFinal" => "683" "link" => array:1 [ …1] ] ] ] ] ] ] 66 => array:3 [ "identificador" => "bib0335" "etiqueta" => "67" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "1990" "volumen" => "82" "paginaInicial" => "774" "paginaFinal" => "780" "link" => array:1 [ …1] ] ] ] ] ] ] 67 => array:3 [ "identificador" => "bib0340" "etiqueta" => "68" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of oral milrinone on mortality in severe chronic heart failure" "autores" => array:1 [ 0 => array:3 [ …3] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM199111213252103" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "1991" "volumen" => "325" "paginaInicial" => "1468" "paginaFinal" => "1475" "link" => array:1 [ …1] ] ] ] ] ] ] 68 => array:3 [ "identificador" => "bib0345" "etiqueta" => "69" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Am Coll Cardiol" "fecha" => "2000" "volumen" => "36" "paginaInicial" => "1903" "paginaFinal" => "1912" "link" => array:1 [ …1] ] ] ] ] ] ] 69 => array:3 [ "identificador" => "bib0350" "etiqueta" => "70" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "2000" "volumen" => "102" "paginaInicial" => "2222" "paginaFinal" => "2227" "link" => array:1 [ …1] ] ] ] ] ] ] 70 => array:3 [ "identificador" => "bib0355" "etiqueta" => "71" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: hemodynamic efficacy, clinical outcome, and economic impact" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1067/mhj.2001.119610" "Revista" => array:6 [ "tituloSerie" => "Am Heart J" "fecha" => "2001" "volumen" => "142" "paginaInicial" => "998" "paginaFinal" => "1002" "link" => array:1 [ …1] ] ] ] ] ] ] 71 => array:3 [ "identificador" => "bib0360" "etiqueta" => "72" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure—a meta-regression analysis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Eur J Heart Fail" "fecha" => "2002" "volumen" => "4" "paginaInicial" => "515" "paginaFinal" => "529" "link" => array:1 [ …1] ] ] ] ] ] ] 72 => array:3 [ "identificador" => "bib0365" "etiqueta" => "73" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy and safety of intravenous levosimendan compared with dobutamina in severe low-output heart failure (the LIDO study): a randomized double blind trial" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2002" "volumen" => "360" "paginaInicial" => "196" "paginaFinal" => "202" "link" => array:1 [ …1] ] ] ] ] ] ] 73 => array:3 [ "identificador" => "bib0370" "etiqueta" => "74" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Short-term intravenous milrinone for acute exacerbation of chronic heart failure. A randomized controlled trial" "autores" => array:1 [ 0 => array:3 [ …3] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "JAMA" "fecha" => "2002" "volumen" => "287" "paginaInicial" => "1541" "paginaFinal" => "1547" "link" => array:1 [ …1] ] ] ] ] ] ] 74 => array:3 [ "identificador" => "bib0375" "etiqueta" => "75" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:1 [ "autores" => array:1 [ 0 => array:3 [ …3] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Eur Heart J" "fecha" => "2002" "volumen" => "23" "paginaInicial" => "1422" "paginaFinal" => "1432" "link" => array:1 [ …1] ] ] ] ] ] ] 75 => array:3 [ "identificador" => "bib0380" "etiqueta" => "76" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Levosimendan vs dobutamine for patients with acute decompensated heart failure. The SURVIVE randomized trial" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jama.297.17.1883" "Revista" => array:6 [ "tituloSerie" => "JAMA" "fecha" => "2007" "volumen" => "297" "paginaInicial" => "1883" "paginaFinal" => "1891" "link" => array:1 [ …1] ] ] ] ] ] ] 76 => array:3 [ "identificador" => "bib0385" "etiqueta" => "77" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/CCM.0b013e3181809846" "Revista" => array:6 [ "tituloSerie" => "Crit Care Med" "fecha" => "2008" "volumen" => "36" "paginaInicial" => "2257" "paginaFinal" => "2266" "link" => array:1 [ …1] ] ] ] ] ] ] 77 => array:3 [ "identificador" => "bib0390" "etiqueta" => "78" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Levosimendan vs dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVE" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/eurjhf/hfn045" "Revista" => array:6 [ "tituloSerie" => "Eur J Heart fail" "fecha" => "2009" "volumen" => "11" "paginaInicial" => "304" "paginaFinal" => "311" "link" => array:1 [ …1] ] ] ] ] ] ] 78 => array:3 [ "identificador" => "bib0395" "etiqueta" => "79" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Right ventricular function in myocardial infarction complicated by cardiogenic shock: Improvement with levosimendan" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/CCM.0b013e3181b0314a" "Revista" => array:6 [ "tituloSerie" => "Crit Care Med" "fecha" => "2009" "volumen" => "37" "paginaInicial" => "3017" "paginaFinal" => "3023" "link" => array:1 [ …1] ] ] ] ] ] ] 79 => array:3 [ "identificador" => "bib0400" "etiqueta" => "80" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of dopamine and norepinephrine in the treatment of shock" "autores" => array:1 [ 0 => array:3 [ …3] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa0907118" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2010" "volumen" => "362" "paginaInicial" => "779" "paginaFinal" => "789" "link" => array:1 [ …1] ] ] ] ] ] ] 80 => array:3 [ "identificador" => "bib0405" "etiqueta" => "81" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology" "autores" => array:1 [ 0 => array:3 [ …3] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/eurheartj/ehi044" "Revista" => array:6 [ "tituloSerie" => "Eur Heart J" "fecha" => "2005" "volumen" => "26" "paginaInicial" => "384" "paginaFinal" => "416" "link" => array:1 [ …1] ] ] ] ] ] ] 81 => array:3 [ "identificador" => "bib0410" "etiqueta" => "82" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)" "autores" => array:1 [ 0 => array:3 [ …3] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/eurheartj/ehn309" "Revista" => array:6 [ "tituloSerie" => "Eur Heart J" "fecha" => "2008" "volumen" => "29" "paginaInicial" => "2388" "paginaFinal" => "2442" "link" => array:1 [ …1] ] ] ] ] ] ] 82 => array:3 [ "identificador" => "bib0415" "etiqueta" => "83" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/CIRCULATIONAHA.109.192065" "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "2009" "volumen" => "119" "paginaInicial" => "e391" "paginaFinal" => "e479" "link" => array:1 [ …1] ] ] ] ] ] ] 83 => array:3 [ "identificador" => "bib0420" "etiqueta" => "84" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intraaortic Balloon Pumping in patients with right ventricular insufficiency after cardiac surgery: parameters to predict failure of IABP support" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1055/s-0029-1185766" "Revista" => array:6 [ "tituloSerie" => "Thorac Cardiovasc Surg" "fecha" => "2009" "volumen" => "57" "paginaInicial" => "324" "paginaFinal" => "328" "link" => array:1 [ …1] ] ] ] ] ] ] 84 => array:3 [ "identificador" => "bib0425" "etiqueta" => "85" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Right ventricular failure resulting from pressure overload: Role of intra-aortic balloon counterpulsation and vasopressor therapy" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jss.2008.06.027" "Revista" => array:5 [ "tituloSerie" => "J Surg Res" "fecha" => "2009" "paginaInicial" => "1" "paginaFinal" => "9" "link" => array:1 [ …1] ] ] ] ] ] ] 85 => array:3 [ "identificador" => "bib0430" "etiqueta" => "86" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Update on management strategies for separation from cardiopulmonary bypass" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/ACO.0b013e328342064a" "Revista" => array:6 [ "tituloSerie" => "Curr Opin Anaesthesiol" "fecha" => "2011" "volumen" => "24" "paginaInicial" => "49" "paginaFinal" => "57" "link" => array:1 [ …1] ] ] ] ] ] ] 86 => array:3 [ "identificador" => "bib0435" "etiqueta" => "87" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prognosis alter the implantation of a Intra-Aortic Balloon Pump in cardiac surgery calculated with a new score" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:8 [ "tituloSerie" => "Circulation" "fecha" => "2002" "volumen" => "106" "numero" => "Suppl. 1" "paginaInicial" => "I203" "paginaFinal" => "I206" "link" => array:1 [ …1] "itemHostRev" => array:3 [ …3] ] ] ] ] ] ] 87 => array:3 [ "identificador" => "bib0440" "etiqueta" => "88" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Crit Care Med" "fecha" => "2010" "paginaInicial" => "38" "link" => array:1 [ …1] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21735727/0000003600000004/v1_201212101018/S2173572712000781/v1_201212101018/en/main.assets" "Apartado" => array:4 [ "identificador" => "409" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Special article" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21735727/0000003600000004/v1_201212101018/S2173572712000781/v1_201212101018/en/main.pdf?idApp=WMIE&text.app=https://medintensiva.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173572712000781?idApp=WMIE" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 36 | 20 | 56 |
2024 October | 272 | 92 | 364 |
2024 September | 439 | 109 | 548 |
2024 August | 339 | 85 | 424 |
2024 July | 352 | 81 | 433 |
2024 June | 287 | 78 | 365 |
2024 May | 266 | 84 | 350 |
2024 April | 189 | 71 | 260 |
2024 March | 203 | 54 | 257 |
2024 February | 232 | 80 | 312 |
2024 January | 304 | 79 | 383 |
2023 December | 146 | 78 | 224 |
2023 November | 124 | 43 | 167 |
2023 October | 130 | 72 | 202 |
2023 September | 42 | 36 | 78 |
2023 August | 21 | 14 | 35 |
2023 July | 31 | 33 | 64 |
2023 June | 38 | 21 | 59 |
2023 May | 21 | 17 | 38 |